BetterScholar BetterScholar

D. O'Connor

Journal of the American Medical Association, American Journal of Kidney Diseases, AJP - Renal Physiology
10
Role
Title
Level Year L/R
🐜 Effect of ramipril vs amlodipine on renal outcomes in hypertensive nephrosclerosis: a randomized controlled trial.
44 auth. L. Agodoa, L. Appel, G. Bakris, G. Beck, J. Bourgoignie, J. Briggs, J. Charleston, D. Cheek, W. Cleveland, J. Douglas, M. Douglas, D. Dowie, M. Faulkner, Avril Gabriel, J. Gassman, ... T. Greene, Y. Hall, L. Hebert, L. Hiremath, K. Jamerson, C. Johnson, J. Kopple, J. Kusek, J. Lash, J. Lea, J. Lewis, M. Lipkowitz, S. Massry, J. Middleton, E. Miller, Keith C. Norris, D. O'Connor, A. Ojo, R. Phillips, V. Pogue, Mahboob Rahman, O. Randall, S. Rostand, G. Schulman, W. Smith, D. Thornley‐Brown, C. Tisher, R. Toto, J. Wright 		9 2001
9
🐜
🐜 Comparison of cross-sectional renal function measurements in African Americans with hypertensive nephrosclerosis and of primary formulas to estimate glomerular filtration rate.
10 auth. J. Lewis, L. Agodoa, D. Cheek, T. Greene, J. Middleton, D. O'Connor, ... A. Ojo, R. Phillips, M. Sika, J. Wright 		7 2001
7
🐜
🐜 Loss of GSTM1, a NRF2 target, is associated with accelerated progression of hypertensive kidney disease in the African American Study of Kidney Disease (AASK).
9 auth. Jamison Chang, Jennie Z. Ma, Qing Zeng, S. Cechova, Adam Gantz, C. Nievergelt, ... D. O'Connor, M. Lipkowitz, T. Le 		5 2013
5
🐜
🐢 The association between CYP3A5 genotype and antihypertensive response
7 auth. H. Ho, S. Hall, D. Flockhart, L. Li, T. Skaar, P. Cadman, ... D. O'Connor 		0 2004
0
🐢